| Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer |
166 |
| Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab |
24 |
| Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer |
19 |
| BRCA1 gene: function and deficiency |
15 |
| Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer |
15 |
| Genetic abnormalities and pathophysiology of MDS |
14 |
| The effects of intraoperative ICG fluorescence angiography in laparoscopic low anterior resection: a propensity score-matched study |
14 |
| Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells |
13 |
| The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV |
13 |
| Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer |
11 |
| Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) |
11 |
| Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database |
10 |
| Immune checkpoint inhibitor-induced sarcoidosis-like granulomas |
10 |
| Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update |
10 |
| Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments |
10 |
| Clinical significance of prognostic nutritional index (PNI) in malignant melanoma |
9 |
| Prognostic and predictive value of plasma d-dimer levels in patients with small-cell lung cancer |
9 |
| Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma |
9 |
| Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia |
8 |
| Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial) |
8 |
| Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors |
8 |
| Identification of SERPINE PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis |
8 |
| Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review |
8 |
| Preoperative predictive factors focused on inflammation nutrition and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy |
8 |
| Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients |
7 |
| Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A) |
7 |
| Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC) |
7 |
| A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width |
7 |
| Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan |
7 |
| A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy |
7 |
| Multi-panel assay of serum autoantibodies in colorectal cancer |
7 |
| Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial) |
6 |
| Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma |
6 |
| Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy |
6 |
| A systematic review of publications on charged particle therapy for hepatocellular carcinoma |
6 |
| A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma |
6 |
| Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy |
6 |
| Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin |
6 |
| External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model |
6 |
| mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival |
6 |
| Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses |
5 |
| Management of hereditary breast and ovarian cancer |
5 |
| Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer |
5 |
| Endoscopic sequestrectomy for skull base osteoradionecrosis in nasopharyngeal carcinoma patients: a 10-year experience |
5 |
| Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients |
5 |
| Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure |
5 |
| Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis |
5 |
| Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma |
5 |
| Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome |
5 |
| Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients |
5 |
